netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 61 to 86 of 86

New Newer

Details
LDL Link Added : NICE TA707: Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancer : https://www.nice.org.uk/guidance/ta707
21/09/2021 11:01:18
(DavidS )
UPD sitematrix Changed from 0 to
21/09/2021 11:00:42
(DavidS )
UPD FurtherInformation Changed from
  • For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
21/09/2021 11:00:42
(DavidS )
UPD Nivolumab NICE TA 707
21/09/2021 11:00:42
(DavidS )
UPD Published from Draft Mode
20/05/2021 13:35:20
(LoweryM )
UPD Nivolumab updated
20/05/2021 13:35:00
(LoweryM )
LDL Link Added : NICE TA684: Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease : https://www.nice.org.uk/guidance/ta684
19/05/2021 16:49:16
(DavidS )
UPD Nivolumab NICE TA684
19/05/2021 16:48:47
(DavidS )
UPD Nivolumab formatting updated
19/05/2021 16:45:39
(DavidS )
LDL Link Added : NICE TA655: Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy : https://www.nice.org.uk/guidance/ta655
26/02/2021 10:28:06
(DavidS )
UPD Nivolumab updated TA655
26/02/2021 10:27:40
(DavidS )
UPD Published from Draft Mode
27/10/2017 15:08:00
(DavidS )
UPD Nivolumab update
27/10/2017 15:07:47
(DavidS )
LDL Link Added : NICE TA462Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma :
26/10/2017 14:32:59
(DavidS )
UPD Nivolumab NICE TA462
26/10/2017 14:32:28
(DavidS )
UPD Nivolumab Published from Draft Mode
26/04/2017 10:25:57
(LoweryM )
UPD Nivolumab updated
26/04/2017 09:00:54
(LoweryM )
UPD Nivolumab a
20/04/2017 11:22:54
(DavidS )
UPD Nivolumab Additional indication following NHS England Commissioning Policy
20/04/2017 11:22:28
(DavidS )
LDL Link Added : NICE TA417: Nivolumab for previously treated advanced renal cell carcinoma : https://www.nice.org.uk/guidance/ta417
01/02/2017 14:42:24
(DavidS )
UPD Nivolumab b
01/02/2017 14:41:56
(DavidS )
UPD Nivolumab b
24/01/2017 16:52:41
(WhitehallJ )
UPD Nivolumab b
24/01/2017 16:52:02
(WhitehallJ )
UPD Nivolumab b
23/01/2017 15:31:15
(WhitehallJ )
UPD Nivolumab 10mg in 1ml concentrate for infusion b
23/01/2017 14:16:25
(WhitehallJ )
UPD Nivolumab (Opdivo®) build
29/11/2016 09:01:19
(DavidS )

 

 
netFormulary